A Velumani's Journey At Thyrocare | What's Next For The Diagnostics Space? | ET Now Exclusive

Sdílet
Vložit
  • čas přidán 28. 08. 2024
  • ET Now Exclusive: Breakdown of A Velumani's Investments. A Velumani's Journey At Thyrocare. What's Next For The Diagnostics Space? Good Time for the sector. 100 Cos with $2-25 Mn investment. Thyrocare saw 40% profitability for 20 years under me. Pharmeasy to see a turnaround by 2030.
    #avelumani #nikunjdalmia #thyrocare #theinterview #etnowexclusive #etnow #englishnews #trending #topnews #stockmarket #businessnews #sharemarketnews
    Subscribe To ET Now For Latest Updates On Stocks, share market, business News, Trading, Crypto Updates | bit.ly/Subscri...
    To Stay Updated Download the Times Now App :-
    Android Google Play : goo.gl/zJhWjC
    Apple App Store : goo.gl/d7QBQZ
    Social Media Links :-
    Twitter - goo.gl/hA0vDt
    Facebook - goo.gl/5Lr4mC
    G+ - goo.gl/hYxrmj
    Website - www.etnownews.com
    Subscribe Now To Our Network Channels:-
    Times Now: bit.ly/Subscri...
    Mirror Now: bit.ly/Subscri...

Komentáře • 2

  • @nafasm
    @nafasm Před 3 měsíci

    Thanks Velumani sir ans Nikul

  • @YogirajMD
    @YogirajMD Před 3 měsíci

    Knowing the api holding founders it is bound to flop